These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2468059)
1. Reduction of size of myocardial infarction with nicorandil, a new antianginal drug, after coronary artery occlusion in dogs. Endo T; Nejima J; Kiuchi K; Fujita S; Kikuchi K; Hayakawa H; Okumura H J Cardiovasc Pharmacol; 1988; 12(5):587-92. PubMed ID: 2468059 [TBL] [Abstract][Full Text] [Related]
2. Comparative effects of nicardipine, a new calcium antagonist, on size of myocardial infarction after coronary artery occlusion in dogs. Endo T; Nejima J; Fujita S; Kiuchi K; Iida N; Kikuchi K; Hayakawa H; Okumura H Circulation; 1986 Aug; 74(2):420-30. PubMed ID: 3731430 [TBL] [Abstract][Full Text] [Related]
3. Sustained beneficial effects of gallopamil (D600) on size of myocardial infarction 24 hours after coronary artery occlusion in dogs. Endo T; Kiuchi K; Sato N; Hayakawa H; Maroko PR Am Heart J; 1990 May; 119(5):1002-7. PubMed ID: 2330858 [TBL] [Abstract][Full Text] [Related]
4. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog. Mizumura T; Nithipatikom K; Gross GJ Cardiovasc Res; 1995 Apr; 29(4):482-9. PubMed ID: 7796441 [TBL] [Abstract][Full Text] [Related]
5. Nicorandil attenuates myocardial acidosis during coronary occlusion in dogs. Abiko Y; Nishimura T; Sakai K Br J Pharmacol; 1984 Feb; 81(2):409-11. PubMed ID: 6231074 [TBL] [Abstract][Full Text] [Related]
6. Effects of nicorandil and nifedipine on protection of ischemic myocardium. Lamping KA; Christensen CW; Pelc LR; Warltier DC; Gross GJ J Cardiovasc Pharmacol; 1984; 6(3):536-42. PubMed ID: 6202983 [TBL] [Abstract][Full Text] [Related]
7. Improved recovery of myocardial segment function following a short coronary occlusion in dogs by nicorandil, a potential new antianginal agent, and nifedipine. Lamping KA; Gross GJ J Cardiovasc Pharmacol; 1985; 7(1):158-66. PubMed ID: 2580137 [TBL] [Abstract][Full Text] [Related]
8. Does the extent of the zone at risk after coronary artery occlusion influence the percentage of the zone that evolves to infarction? Endo T; Kiuchi K; Sato N; Hayakawa H; Okumura H Cardiology; 1990; 77(2):112-20. PubMed ID: 2397488 [TBL] [Abstract][Full Text] [Related]
9. Infarct size-reducing effect of nicorandil is mediated by the KATP channel but not by its nitrate-like properties in dogs. Mizumura T; Nithipatikom K; Gross GJ Cardiovasc Res; 1996 Aug; 32(2):274-85. PubMed ID: 8796114 [TBL] [Abstract][Full Text] [Related]
10. Reduction in myocardial hemorrhage and the extent of necrosis by gallopamil (D600) in dogs with coronary artery reperfusion. Endo T; Sato N; Hayakawa H; Maroko PR J Cardiovasc Pharmacol; 1991 Nov; 18(5):739-45. PubMed ID: 1723771 [TBL] [Abstract][Full Text] [Related]
11. Salutary action of nicorandil, a new antianginal drug, on myocardial metabolism during ischemia and on postischemic function in a canine preparation of brief, repetitive coronary artery occlusions: comparison with isosorbide dinitrate. Pieper GM; Gross GJ Circulation; 1987 Oct; 76(4):916-28. PubMed ID: 2958176 [TBL] [Abstract][Full Text] [Related]
12. [Cardioprotective effects of K(ATP) channel opener nicorandil during ischemia/ reperfusion in dogs]. Feng L; Qiu J; Ma J; Huang XB; Cha DG; Bin JP Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Mar; 17(3):157-60. PubMed ID: 15760526 [TBL] [Abstract][Full Text] [Related]
13. The effects of cytochrome C on the extent of myocardial infarction and regional function of the ischemic myocardium. Zalewski A; Goldberg S; Krol R; Maroko PR Am Heart J; 1987 Jan; 113(1):124-9. PubMed ID: 3026160 [TBL] [Abstract][Full Text] [Related]
14. Comparative effects of nicorandil, a nicotinamide nitrate derivative, and nifedipine on myocardial reperfusion injury in dogs. Gross GJ; Warltier DC; Hardman HF J Cardiovasc Pharmacol; 1987 Nov; 10(5):535-42. PubMed ID: 2447402 [TBL] [Abstract][Full Text] [Related]
15. Relation of myocardial salvage to size of myocardium at risk in dogs. Zalewski A; Goldberg S; Faria DB; Krol R; Maroko PR Am J Cardiol; 1985 Dec; 56(15):974-7. PubMed ID: 4072932 [TBL] [Abstract][Full Text] [Related]
16. Effects of nicorandil, a new antianginal agent, and nifedipine on collateral blood flow in a chronic coronary occlusion model. Lamping KA; Warltier DC; Hardman HF; Gross GJ J Pharmacol Exp Ther; 1984 May; 229(2):359-63. PubMed ID: 6232374 [TBL] [Abstract][Full Text] [Related]
17. Enhanced subendocardial perfusion distal to a flow-limiting coronary artery stenosis in dogs: comparative effects of nicorandil, a potential new antianginal agent, and nitroglycerin. Gross GJ; Warltier DC; Hardman HF; Lamping KA J Cardiovasc Pharmacol; 1985; 7(5):977-82. PubMed ID: 2413311 [TBL] [Abstract][Full Text] [Related]
18. Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs. Galiè N; Guarnieri C; Ussia GP; Zimarino M; Traini AM; Parlangeli R; Vaona I; Branzi A; Magnani B J Cardiovasc Pharmacol; 1995 Sep; 26(3):477-84. PubMed ID: 8583791 [TBL] [Abstract][Full Text] [Related]
19. Effects of nicorandil on coronary circulation and myocardial ischemia. Gross G; Pieper G; Farber NE; Warltier D; Hardman H Am J Cardiol; 1989 Jun; 63(21):11J-17J. PubMed ID: 2525319 [TBL] [Abstract][Full Text] [Related]
20. Reduction in infarct size by the phospholipase inhibitor quinacrine in dogs with coronary artery occlusion. Chiariello M; Ambrosio G; Cappelli-Bigazzi M; Perrone-Filardi P; Tritto I; Nevola E; Golino P Am Heart J; 1990 Oct; 120(4):801-7. PubMed ID: 2220533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]